ROCKEFELLER CAPITAL MANAGEMENT L.P. – BioMarin Pharmaceutical Inc. Transaction History
ROCKEFELLER CAPITAL MANAGEMENT L.P. portfolio value:
$86.41M
portfolio value
ROCKEFELLER CAPITAL MANAGEMENT L.P. quarter portfolio value change:
+2.29%
quarter
BioMarin Pharmaceutical Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -8.78% | -98.18K shares | -6.2M | $84.77 | 1.01M |
| Q2 2022 | share | Decrease | -1.30% | -14.73K shares | 5.31M | $82.87 | 1.11M |
| Q1 2022 | share | Decrease | -0.66% | -7.50K shares | -13.40M | $77.1 | 1.13M |
| Q4 2021 | share | Decrease | -1.04% | -12.02K shares | 11.67M | $89.08 | 1.13M |
| Q3 2021 | share | Increase | +41.60% | 338.40K shares | 21.15M | $77.29 | 1.15M |
| Q2 2021 | share | Increase | +6.99% | 53.16K shares | 10.46M | $83.44 | 813.45K |
| Q1 2021 | share | Decrease | -13.64% | -120.04K shares | -19.78M | $75.51 | 760.29K |
| Q4 2020 | share | Increase | +0.55% | 4.8K shares | 10.58M | $87.69 | 880.33K |
| Q3 2020 | share | Increase | +62.11% | 335.43K shares | -6K | $76.08 | 875.53K |
| Q2 2020 | share | Increase | +6721.13% | 532.17K shares | 65.94M | $123.34 | 540.09K |
| Q1 2020 | share | Increase | +99.85% | 3.95K shares | 334K | $84.5 | 7.91K |
| Q4 2019 | share | Increase | +1.90% | 74 shares | 73K | $84.55 | 3.96K |
| Q3 2019 | share | Increase | +414.29% | 3.13K shares | 197K | $67.4 | 3.88K |
| Q2 2019 | share | Decrease | -45.10% | -621 shares | -57K | $85.65 | 756 |
| Q1 2019 | share | Increase | 0.00% | 1.37K shares | 122K | $88.83 | 1.37K |